LAGENIO Unveils Next-Gen AI-Powered Kids Smartwatch with Simcard at IFA 2025
9.9.2025 08:07:00 CEST | Business Wire | Press Release
LAGENIO, a global leader in kid’s smartwatches, is set to debut its next-generation innovation at IFA 2025 in Berlin, Germany, Booth NO: H27h-12. LAGENIO has unveiled two new models for Europe market: the K9, a premium AI-powered watch phone, and the K3, a creative entry-level model. Designed as a safe first phone alternative for children ages 4 to 12, both devices combine secure communication and parental controls with features that encourage physical activity and healthy digital habits.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250905079305/en/
LAGENIO kids smartwatches in colorful designs with fun cartoon watch faces, fitness tracking, safety features, and educational functions
“Parents want to give their kids independence without compromising safety, and kids want technology that feels exciting and fun,” said Li Leung, CEO of LAGENIO. “With the new LAGENIO platform, we have combined performance, design, and child-friendly features to deliver a smartwatch that kids love—and parents can feel secure about.”
LAGENIO K9 — The World’s First AI 4G Kids Watch
LAGENIO K9 kid’s smartwatch delivers comprehensive hardware upgrades, including a AMOLED display, a slimmer, stylish design, and a higher-frequency CPU for smooth and responsive performance.
What truly distinguishes the K9 is its AI-powered software based on ChatGPT. A lightweight local AI model provides personalized assistance tailored to each child’s needs, including drawing guidance, question answering, writing support, and storytelling.
With these intelligent capabilities, the K9 redefines the kid’s smartwatch category for the AI era, offering smart, reliable, and interactive experiences that empower kids while giving parents peace of mind.
LAGENIO K3 — Streamlined functions dedicated to children’s safety and connection
The K3 focuses on what matters most: kid’s safety and seamless communication. Equipped with reliable calling, real-time location tracking, and durable kid-friendly design, the K3 offers kids more color options for housing combinations, ensures parents can stay connected with peace of mind while kids enjoy greater creativity.
About LAGENIO
Founded in 2019, LAGENIO is a global leader in 4G kid’s smartwatches. We are committed to creating a world where innovation and care thrive to empower families worldwide. LAGENIO has become a trusted brand for families worldwide. The company serves more than 36 million users across 45 countries.
LAGENIO cares about data security and data privacy. All user data will be saved in local Europe server without transmission to any other country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250905079305/en/
Contacts
SHENZHEN LAGENIO TECHNOLOGY CO., LIMITED
sales@lagenio.com
Visit: www.lagenio.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.lagenio.com
&esheet=54319565&newsitemid=20250905079305&lan=en-US&anchor=www.lagenio.com&inde
x=1&md5=917f1ca9d0c4705b799b953dad8ae7b0
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release
Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of
Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 15:00:00 CEST | Press Release
Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom